Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Clasificación en acciones #31255
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Precio por acción
$0.39
Capitalización bursátil
$13.79M
Cambio (1 día)
-13.53%
Cambio (1 año)
-68.80%
País
IL
Comercio NeuroSense Therapeutics Ltd. (NRSN)

Categoría

Historial de desdoblamientos de acciones de NeuroSense Therapeutics Ltd. (NRSN)
La acción NeuroSense Therapeutics Ltd. (símbolo: NRSN) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 18, 2026.
Una acción NRSN comprada antes de Aug 18, 2026 equivaldría hoy a 0 acciones NRSN.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE